Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kangfuxiaoyanshuan is a Traditional Chinese Medicine (TCM) suppository formulation widely utilized in China for the treatment of gynecological inflammatory conditions, particularly chronic pelvic inflammatory disease (PID), adnexitis, and endometritis. The product is composed of eight botanical ingredients, including *Sophora flavescens*, *Leonurus japonicus*, and *Phellodendron amurense*, which provide a combination of anti-inflammatory, antibacterial, and analgesic properties. It is typically administered rectally or vaginally to deliver active constituents directly to the pelvic region, where it helps to reduce pelvic congestion, alleviate pain, and lower levels of inflammatory cytokines. Clinical studies often evaluate its efficacy both as a monotherapy and in combination with other interventions like physical therapy or antibiotics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kangfuxiaoyanshuan.